Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
13 10 2020
Historique:
received: 19 03 2020
accepted: 20 05 2020
pubmed: 23 5 2020
medline: 12 3 2021
entrez: 23 5 2020
Statut: ppublish

Résumé

Historical data regarding time to viral rebound following analytical treatment interruption (ATI) have been used to determine therapeutic efficacy in HIV cure trials; however, such data were collected from studies conducted a decade or more ago and included participants receiving older antiretroviral therapy (ART) regimens with infrequent virologic monitoring. We conducted a study of 22 HIV-infected participants receiving modern ART to determine the kinetics of plasma viral rebound following ATI. Our data suggest that modern ART does not alter kinetics of viral rebound when compared to previous regimens and that immunologic interventions may be necessary to achieve ART-free virologic remission. Clinical Trials Registration ClinicaTrials.gov identifier: NCT03225118.

Identifiants

pubmed: 32443148
pii: 5842227
doi: 10.1093/infdis/jiaa270
pmc: PMC7751567
doi:

Substances chimiques

Anti-Retroviral Agents 0

Banques de données

ClinicalTrials.gov
['NCT03225118']

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1655-1659

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Références

Nat Rev Immunol. 2020 Aug;20(8):471-482
pubmed: 32051540
J Infect Dis. 2018 Nov 5;218(12):1954-1963
pubmed: 30085241
AIDS. 2016 Jan 28;30(3):343-53
pubmed: 26588174
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15109-14
pubmed: 10611346
Nature. 1997 May 8;387(6629):188-91
pubmed: 9144290
Curr Top Microbiol Immunol. 2018;417:23-41
pubmed: 29071475
PLoS Pathog. 2018 Jan 11;14(1):e1006792
pubmed: 29324842
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
Cancer Cell. 2014 Dec 8;26(6):923-937
pubmed: 25465800
Nat Med. 2018 Jul;24(7):923-926
pubmed: 29892063
Nat Immunol. 2015 Jun;16(6):584-9
pubmed: 25990814
Science. 2014 Jul 11;345(6193):169-74
pubmed: 25013067
AIDS. 2019 Apr 1;33(5):773-791
pubmed: 30883388
Sci Transl Med. 2017 Dec 6;9(419):
pubmed: 29212716
Lancet HIV. 2019 Apr;6(4):e259-e268
pubmed: 30885693

Auteurs

Michael C Sneller (MC)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Erin D Huiting (ED)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Katherine E Clarridge (KE)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Catherine Seamon (C)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Jana Blazkova (J)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Jesse S Justement (JS)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Victoria Shi (V)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Emily J Whitehead (EJ)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Rachel F Schneck (RF)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Michael Proschan (M)

Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Susan Moir (S)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Anthony S Fauci (AS)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Tae-Wook Chun (TW)

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH